NIPH Stock Overview
Develops, produces, and sells pharmaceutical products in Egypt. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
+ 2 more risks
EI- Nile Co. for Pharmaceuticals and Chemical Industries Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م60.40 |
| 52 Week High | ج.م114.37 |
| 52 Week Low | ج.م44.60 |
| Beta | 0.23 |
| 1 Month Change | 10.22% |
| 3 Month Change | -15.72% |
| 1 Year Change | -28.82% |
| 3 Year Change | 111.34% |
| 5 Year Change | 157.90% |
| Change since IPO | 304.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| NIPH | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | 14.1% | 1.8% | 0.2% |
| 1Y | -28.8% | 27.7% | 28.7% |
Return vs Industry: NIPH underperformed the EG Pharmaceuticals industry which returned 28.3% over the past year.
Return vs Market: NIPH underperformed the EG Market which returned 28.9% over the past year.
Price Volatility
| NIPH volatility | |
|---|---|
| NIPH Average Weekly Movement | 19.9% |
| Pharmaceuticals Industry Average Movement | 8.0% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in EG Market | 9.3% |
| 10% least volatile stocks in EG Market | 3.5% |
Stable Share Price: NIPH's share price has been volatile over the past 3 months compared to the EG market.
Volatility Over Time: NIPH's weekly volatility has increased from 11% to 20% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | n/a | Eldin Hajjaj | www.nilepharma.com.eg |
EI- Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products in Egypt. The company offers tablets, capsules, ampoules, powders, gels and creams, syrups, suppositories, lotions, shampoos, ointments, mouthwashes, powder solutions, and nasal and midodrine drops. It also exports its products to the countries in the Middle East.
EI- Nile Co. for Pharmaceuticals and Chemical Industries Fundamentals Summary
| NIPH fundamental statistics | |
|---|---|
| Market cap | ج.م611.55m |
| Earnings (TTM) | ج.م24.65m |
| Revenue (TTM) | ج.م885.62m |
24.8x
P/E Ratio0.7x
P/S RatioIs NIPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NIPH income statement (TTM) | |
|---|---|
| Revenue | ج.م885.62m |
| Cost of Revenue | ج.م707.75m |
| Gross Profit | ج.م177.88m |
| Other Expenses | ج.م153.23m |
| Earnings | ج.م24.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.43 |
| Gross Margin | 20.08% |
| Net Profit Margin | 2.78% |
| Debt/Equity Ratio | 110.6% |
How did NIPH perform over the long term?
See historical performance and comparison